Loading...

國家中醫藥研究所和訊聯細胞智藥共同簽屬開發中草藥外泌體合作協議書

前方從左到右:訊聯細胞智藥李黛苹總經理、訊聯細胞智藥蔡政憲董事長、衛生福利部國家中醫藥研究所所長蘇奕彰教授、衛生福利部國家中醫藥研究所副所長邱文慧研究員


國家中醫藥研究所所長蘇奕彰與訊聯細胞智藥董事長蔡政憲於2025年2月12日共同簽署了中草藥外泌體開發合作協議。

此合作結合雙方研發團隊的專業知識,推動中草藥外泌體的研究與應用,進一步提升中醫藥創新發展的國際競爭力。



訊聯細胞智藥蔡政憲董事長、衛生福利部國家中醫藥研究所所長蘇奕彰教授


中草藥外泌體(Herbal-derived Exosomes)是從中草藥中提取的奈米級胞外囊泡,能夠承載並傳遞活性成分,有助於增強藥效、提高生物利用度,並展現跨物種應用的潛力。

近年來,外泌體技術在再生醫學、免疫調節及精準醫療領域備受矚目,尤其在醫美與皮膚修復方面具有極大潛力。

研究顯示,中草藥外泌體可促進膠原蛋白增生、加速皮膚再生、改善發炎反應,為未來開發天然、高效、安全的醫美與護膚產品提供了新的契機。




簽約儀式後,訊聯細胞智藥團隊特別參訪國家中醫藥研究所的尖端奈米中藥實驗室與典藏豐富標本館,深入了解中草藥的現代化研發技術與豐富的中藥資源,為未來的合作奠定更堅實的基礎。


BIONET Therapeutics Corp. and National Research Institute of Chinese Medicine Sign Collaboration Agreement on Herbal-Derived Exosome Development

On February 12, 2025, Prof./Dr. Su Yi-Chang, Director of the National Research Institute of Chinese Medicine, MOHW, and Dr. Chris Tsai, Chairman of BIONET Therapeutics Corp., formally signed a collaboration agreement to advance the research and application of herbal-derived exosomes. This partnership leverages the expertise of both research teams to drive innovation in traditional Chinese medicine (TCM) and enhance its global competitiveness.


Herbal-Derived Exosomes: A Breakthrough in TCM and Biotechnology

Herbal-derived exosomes are nanoscale extracellular vesicles extracted from medicinal herbs, capable of carrying and delivering active ingredients. They enhance bioavailability, optimize therapeutic efficacy, and hold cross-species application potential. In recent years, exosome technology has gained significant attention in regenerative medicine, immunomodulation, and precision therapy, particularly in aesthetics and skin regeneration. Research suggests that herbal-derived exosomes can stimulate collagen production, accelerate skin repair, and reduce inflammation, presenting a promising avenue for the development of natural, effective, and safe medical aesthetic and skincare products.


Following the signing ceremony, the BIONET Therapeutics Corp. team visited the National Research Institute of Chinese Medicine’s state-of-the-art Nano TCM Laboratory and extensive herbal specimen archive. This visit provided deeper insights into modern TCM research and its vast medicinal resources, laying a solid foundation for future collaboration.


◆ 新聞來源衛生福利部國家中醫藥研究所

◆ 重訊公告:訊聯智藥與衛生福利部國家中醫藥研究所簽署中草藥外泌體開發之合作協議書

BIONET Corp. © 2022 All Rights Reserved.